Toru Dejima
Sagamihara, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Time course of restenosis with "black hole" on intravascular ultrasound after implantation of platinum-chromium everolimus-eluting stent: Assessment using optical frequency-domain imaging.
Journal: Journal of cardiology cases
Published: June 13, 2017
Possible combinatorial effects of current smoking and alcohol intake on chronic kidney disease in a Japanese nationwide cross-sectional survey.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: April 28, 2017
Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
Journal: Journal of the American Heart Association
Published: March 21, 2015
Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: a multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2).
Journal: Atherosclerosis
Published: September 19, 2014
Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease.
Journal: BioMed research international
Published: February 21, 2014
Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders.
Journal: International journal of medical sciences
Published: January 14, 2014
Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
Journal: Cardiovascular research
Published: November 06, 2013
Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
Journal: Journal of the American Heart Association
Published: August 02, 2013
Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.
Journal: International journal of molecular sciences
Published: May 13, 2013
Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension.
Journal: Kidney international
Published: May 02, 2013
The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.
Journal: Current pharmaceutical design
Published: October 02, 2012
Last Updated: 09/26/2026